Michael Heltzen

Mr. Michael Heltzen is a high-net-worth investor. Mr. Heltzen is a Co-Founder & serves as Chief Executive Officer at AllSeq. He is a Co-Founder and serves as Chief Executive Officer at Cardea. Mr. Heltzen served as Chief Executive Officer at Oarao Therapeutics. He is a Co-Founder at EXO Incubator. He co-founded Nanosens Innovations. He serves as a Board Member at CRISPRQC. He held leadership positions in CLC bio, BGI, Nanosens, and BlueSEQ. He manages his own investments.